Sarepta Therapeutics Stock Plummets After Q1 Results: Here's Why

benzinga.com/general/biotech/25/05/45239803/sarepta-therapeutics-stock-plummets-after-q1-results-heres-why

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shares are sinking after the company released its first-quarter results after Tuesday's closing bell. Here's a look at the details from the report.
The Details: Sarepta Therapeutics reported quarterly losses of $3.42 per share, which missed the…

This story appeared on benzinga.com, 2025-05-06 21:50:12.
The Entire Business World on a Single Page. Free to Use →